Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
NCT00002748
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
38
Enrollment
OTHER
Sponsor class
Conditions
Neuroblastoma
Interventions
BIOLOGICAL:
gene-modified tumor cell vaccine therapy
BIOLOGICAL:
interleukin-2 gene
Sponsor
St. Jude Children's Research Hospital
Collaborators
[object Object]